Primer: Acadia Pharmaceuticals (ACAD US) - Aug 2026
ACADIA is transitioning into a commercial-stage biopharmaceutical company with two approved, revenue-generating products, NUPLAZID and DAYBUE,...
92 Views
𝛼SK or SearchENTITY
Acadia Pharmaceuticals (ACAD US)
Acadia Pharmaceuticals (ACAD US)
28
Analysis
Health Care • United States
ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. The company is currently working on the treatment of induced dysfunction in Parkinson's disease ,schizophrenia, neuropathic pain and glaucoma.
morex